IDSMB Agrees On Basilea Isavuconazole Phase III Trial Futility Analysis
The primary goal of this phase III study is to demonstrate statistical non-inferiority of isavuconazole versus the comparator, current standard- of-care voriconazole in the treatment of invasive Aspergillus
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.